LATE-BREAKING CLINICAL TRIALS

Tuesday, November 4, 2025

10:45am - 12:00pm PT

Moderator(s)

Parag Patel, MD, MS

Professor
Medical College of Wisconsin
Interventional Radiology
Milwaukee, Wisconsin, United States

Disclosure(s): BD (formerly Bard): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Boston Scientific: Advisory Board; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Cook Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Medtronic: Advisory Board
Penumbra: Advisory Board; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Philips: Consultant

Panel(s)

William Gray, MD

System Chief of Cardiovascular Services, Main Line Health
Lankenau Heart Institute
Interventional Cardiology
Wynnewood, Pennsylvania, United States

Disclosure(s): Abbott Vascular: Grants/Research Support Recipient
Boston Scientific: Consultant; Grants/Research Support Recipient
Edwards Lifesciences: Consultant; Grants/Research Support Recipient
Efemerol: Consultant
Gore and Associates: Consultant
Medtronic: Consultant; Grants/Research Support Recipient
Philips: Consultant; Grants/Research Support Recipient
Shockwave: Consultant; Grants/Research Support Recipient
Miguel Montero-Baker, MD

Chief of Vascular Surgery
HOPE Clinical Innovation Center
Vascular Surgery
Houston, Texas, United States

Disclosure(s): No financial relationships to disclose
Lorenzo Patrone, MD

Consultant Vascular Interventional Radiologist
Ospedale San Giovanni di Dio - USL Tuscany Centre
Interventional Radiology
London, England, United Kingdom

Disclosure(s): Abbott Vascular: Consultant
Angiodroid: Consultant
Asahi: Consultant
BD (formerly Bard): Consultant
Bentley: Consultant
Biotronik: Consultant
Cook Medical: Consultant
Immertec: Stockholder - Privately-held company
Pathfinder Medical: Consultant; Stockholder - Privately-held company
Shockwave: Consultant
Terumo: Consultant
John Rundback, MD

Managing Partner
Advanced Interventional & Vascular Services, LLP
Interventional Radiology
Teaneck, New Jersey, United States

Disclosure(s): Abbott Vascular: Consultant; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Amplitude Vascular Systems: Grants/Research Support Recipient
AngioDynamics: Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Aveera Medical: Grants/Research Support Recipient; Stockholder - Privately-held company
BD (formerly Bard): Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Bolton (now Terumo): Consultant; Grants/Research Support Recipient
Boston Scientific: Consultant; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
CLI GLOBAL SOCIETY: Advisory Board
Cordis: Consultant
Evident: Stockholder - Privately-held company
Inari Medical: Consultant; Grants/Research Support Recipient
Inquis: Stockholder - Privately-held company
JanaCare: Stockholder - Privately-held company
LimFlow: Grants/Research Support Recipient
MED ALLIANCE: Grants/Research Support Recipient
Medtronic: Consultant; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Philips: Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Post Surveillance Registry: Grants/Research Support Recipient
Protexa: Stockholder - Privately-held company
Reflow Medical: Grants/Research Support Recipient
Reva Medical: Grants/Research Support Recipient
Solven: Stockholder - Privately-held company
Summa: Stockholder - Privately-held company
Surmodics: Grants/Research Support Recipient
TELEFLEX: Consultant
Veryan: Consultant
Vesper: Grants/Research Support Recipient
TS

Tamara Syrek Jensen

Disclosure information pending.
Thomas Zeller, MD

Head Physician Department of Angiology
Universitaets-Herzzentrum Freiburg - Bad Krozingen
Bad Krozingen, Germany

Disclosure information pending.

Presentations:

10:45am - 10:55am PT

Transcatheter Arterialization of the Deep Veins: Initial 6-Month Outcomes From the PROMISE III Trial
Speaker: Daniel Clair, MD – Vanderbilt University Medical Center
10:55am - 11:00am PT

Panel Discussion
11:00am - 11:10am PT

Peripheral Retrievable Stent Therapy: DEEPER REVEAL Clinical Trial 6-Month Outcomes
Speaker: Mahmood Razavi, MD – St Joseph Heart & Vascular Center
11:10am - 11:15am PT

Panel Discussion
11:15am - 11:25am PT

MOTIV BTK RCT: Safety and Effectiveness Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold Compared with Plain Balloon Angioplasty for the Treatment of Infrapopliteal Lesions–Primary Safety Endpoint
Speaker: Ehrin Armstrong, MD – Swedish Medical Center
11:25am - 11:30am PT

Panel Discussion
11:30am - 11:40am PT

One-Year Outcomes From the FORWARD PAD IDE and Feasibility Studies of the Treatment of Calcified PAD With a Novel Forward Peripheral Intravascular Lithotripsy System
Speaker: Andrew Holden – Auckland Hospital
11:40am - 11:45am PT

Panel Discussion
11:45am - 11:55am PT

Results From Pulse IVL™ to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Peripheral Artery Disease: POWER PAD II
Speaker: D. Christopher Metzger, MD – Ballad CVA Heart Institute
11:55am - 12:00pm PT

Panel Discussion